Phelan M. Autologous Cell Therapies Do Not Represent a Public Health Risk and Should Not Be Regulated Like Drugs CellR4 2013; 1 (3): e592 I would like to be a voice for patients and make a case that future promising ESC & IPSC and manufactured cell based products are not confused with Autologous Stem Cell …